who discovered glp-1 agonists PDB-101: Molecule of the Month: Receptor Discovery of GLP-1–Based Drugs for
Description
doi: 10.1186/s13024-023-00676-7
They are vital in developing novel therapies, especially in oncology and rare diseases
Main outcome measures The primary outcome was suicidality, defined as a composite of suicidal ideation, self-harm, and suicide
doi:10.2337/db19-983-P 47
Proper Disposal Dispose of all materials in accordance with institutional biosafety, chemical waste, and hazardous material protocols
doi:10.1056/NEJMoa1411892 91
